We previously showed that an angiotensin-converting enzyme inhibitor (captopril) or an angiotensin receptor blocker (losartan) reduced infarct size and improved endothelial function in a rat model of ischaemia-reperfusion. The present study was undertaken to see if aspirin (ASA) antagonised the beneficial effects of captopril or losartan.
Methods
One hundred and fourteen Sprague-Dawley rats were randomised into six groups; Control, ASA, captopril, losartan, ASA+captopril, and ASA+losartan. ASA, captopril or losartan were given at a concentration of 40 mg/kg/day in drinking water. After six weeks of pre-treatment, the rats were subjected to 17 minutes of left anterior descending coronary artery occlusion and 120 minutes of reperfusion, with haemodynamic and ECG monitoring. During the reperfusion period, the effective refractory period (ERP), ventricular fibrillation threshold (VFT) and bleeding time (BT) were measured. In fresh aortic rings precontracted with phenylephrine, endothelium-dependent and -independent relaxations were assessed using
acetylcholine and nitroglycerin. Results
Haemodynamic changes were not different between the groups. Serum ASA concentrations were 0.5, 1.1 and 0.6 mg/dl in the ASA, ASA+captopril and ASA+losartan groups, respectively, and BT was prolonged (p<0.01). ASA alone reduced endothelium-dependent relaxation (-29±8 vs. -69±11%, p<0.01), but did not change endothelium-independent relaxation. ASA did not affect endothelial relaxation induced by acetylcholine in the presence of either captopril or losartan. Angiotensin I and ERP were elevated by captopril and losartan. Angiotensin II and VFT were elevated by losartan. ASA with captopril, captopril and losartan equally reduced infarct size, compared with control (39±3, 39±4 and 39±5 vs. 53±3%, all p<0.05).
Conclusions
Captopril and losartan had similar cardiovascular protective effects in a rat model of ischaemia-reperfusion. Aspirin did not attenuate the cardiovascular protective effects of captopril or losartan.
Hubert C., Houot A.-M, Corvol P.,Soubrier F.Structure of the angiotensin I-converting enzyme gene: two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem1991;266:15377-83.
2.
Pieruzzi F.,Abassi ZA, Keiser HRExpression of reninangiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation1995;92:3105-12.
3.
Dakik HA, Mahmarian JJ, Verani MS, Farmer JA, Zhao G., Marian AJAssociation of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. J Am Coll Cardiol1997;29:1468-73.
4.
Zhu B-Q. , Sun Y-P., Sievers RE et al. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol2000 ;35:787-95.
5.
Sun Y-P. , Zhu B-Q., Browne AEM et al. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function . J Cardiovasc Pharmacol Ther2001;6:175-81.
6.
Zhu B-Q. , Sun Y-P., Sievers RE et al. Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor. JRAAS2001;2:129-33.
7.
Sun Y-P. , Zhu B-Q., Sievers RE, Isenberg WM, Parmley WWAspirin inhibits platelet activity but does not attenuate experimental atherosclerosis. Am Heart J1993;125:79-86.
8.
Ahmed A.Interaction between aspirin and angiotensin-converting enzyme inhibitors: Should they be used together in older adults with heart failure?J Am Geriatr Soc2002;50: 1293-6.
9.
Teerlink JR, Massie BMThe interaction of ACE inhibitors and aspirin in heart failure: Torn between two lovers. Am Heart J1999;138:193-7.
10.
Wong J., Chou L., Reid IARole of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. J Clin Invest1993;91:1516-20.
11.
Matsukawa S. , Keil LC, Reid IARole of endogenous angiotensin II in the control of vasopressin secretion during hypovolemia and hypotension in conscious rabbits . Endocrinol1991;128:204-10.
12.
Sievers RE, Schmiedl U., Wolfe CL et al. A model of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med1989;10:172-81.
13.
Zhu B-Q. , Sievers RE, Sun Y-P., Morse-Fisher N., Parmley WW, Wolfe CLIs the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function?Am Heart J1994;127:744-55.
14.
Hutchison SJ , Glantz SA, Zhu B-Q. et al. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol1998;32:1463-7.
15.
Abdelnoor M. , Landmark K.Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms. Cardiology1999;91:119-26.
16.
Mukamal KJ, Mittleman MA, Maclure M., Sherwood JB, Goldberg RJ, Muller JERecent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction. Am Heart J1999;137:1120-8.
17.
Alhaddad IA , Tkaczevski L., Siddiqui F., Mir R., Brown EJ Jr.Aspirin enhances the benefits of late reperfusion on infarct shape.A possible mechanism of the beneficial effects of aspirin on survival after myocardial infarction . Circulation1995;91: 2819-23.
18.
Linz W., Scholken BA, Han YFBeneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol1986;8(suppl 10):S91-9.
19.
Harada K., Komuro I., Hayashi D., Sugaya T., Murakami K., Yazaki Y.Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation1998;97: 315-17.
20.
Rodrigo E., Maeso R., Munoz-Garcia R. et al. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens1997;15:613-18.
21.
Dagenais F. , Buluran J., Cartier R.Effects of chronic administration of captopril on vascular reactivity of the rat aorta. Annales de Chirurgie1997;51:899-905.
22.
Noon JP, Walker BR, Hand MF, Webb DJImpairment of forearm vasodilation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res1998 ;38:480-4.
23.
Husain S., Andrews NP, Mulcahy D., Panza JA, Quyyumi AAAspirin improves endothelial dysfunction in atherosclerosis. Circulation1998;97:716-20.
24.
Monobe H.,Yamanari H., Nakamura K., Ohe T.Effects of lowdose aspirin on endothelial function in hypertensive patients . Clin Cardiol2001;24:705-09.
25.
Massie BM, Teerlink JRInteraction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined. Am J Med2000;109:431-3.
26.
Hall D.The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not. J Am Coll Cardiol2000;35:1808-12.
27.
Hall D.Controversies in heart failure.Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?Cardiol Clin2001; 19:597-603.
28.
Peterson JG ,Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MSEvaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Am J Med2000;109:371-7.
29.
Harjai KJ, Nunez E.,TurgutT,Newman J.Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure. Am J Cardiol2001; 87:483-7.
30.
Teo KK,Yusuf S., Pfeffer M. et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet2002;360:1037-43.
31.
Latini R., Santoro E., Masson S. et al. GISSI-3 investigators. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 trial. Heart Dis2000;2:185-90.
32.
Davie AP, McMurray JJEffect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. Br J Clin Pharmacol2002;53:37-42.
33.
Lapane KL, HumeAL, Barbour MM, Lipsitz LADoes aspirin attenuate the effect of angiotensin-converting enzyme inhibitors on health outcomes of very old patients with heart failure?J Am Geriatr Soc2002;50:1198-204.
34.
Krumholz HM , Chen YT, Wang Y., Radford MJAspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med2001 ;161:538-44.
35.
Latini R., Tognoni G., Maggioni AP et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systemic overview of individual data from 96,712 randomized patients. Angiotensin-converting enzyme inhibitor myocardial infarction collaborative group. J Am Coll Cardiol2000;35:1801-07.
36.
Cleland JG, John J., Houghton T.Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?Curr Opin Nephrol Hypertens2001;10:625-31.
37.
Ahmed A.Interaction between aspirin and angiotensinconverting enzyme inhibitors: should they be used together in older adults with heart failure?J Am Geriatr Soc2002;50:1293
38.
Hurlen M., Hole T., Seljeflot I., Arnesen H.Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction .Eur J Heart Fail 2001;3:203-07.
39.
Tenenbaum A. , Grossman E., Shemesh J., Fisman EZ, Nosrati I., Motro M.Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens2000;13:776-82.
40.
Fisman EZ, Grossman E., Motro M., Tenenbaum A.Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens2002;16:379-83.
41.
Nawarskas JJ , Spinler SAUpdate on the interaction between aspirin and angiotensin-converting enzyme inhibitors. Pharmacotherapy2000;20:698-710.
42.
Meune C., Mahe I., Mourad JJ et al. Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review. Eur J Clin Pharmacol2000;56:609-20.
43.
Nawarskas JJ , Townsend RR, Cirigliano MD, Spinler SAEffect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. Am J Hypertens1999;12:784-9.
44.
Guazzi M., Melzi G.,Agostoni P.Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol1997;30:1572-6.
45.
Rico LA, Garcia R., Gomez J., Farre J., Casado S., Lopez-Farre A.Effect of losartan on human platelet activation. J Hypertens1999;17:447-52.
